medigraphic.com
ISSN 1527-3172 (Digital)

2010, Número 3

<< Anterior Siguiente >>

MEDICC Review 2010; 12 (3)


Prevalence of stroke and associated risk factors in older adults in Havana city and Matanzas provinces, Cuba (10/66 Population-Based Study)

Llibre JJ, Valhuerdi A, Fernández O, Llibre JC, Porto R, López AM, Marcheco B, Moreno C

Idioma: Ingles.
Referencias bibliográficas: 48
Paginas: 20-26
Archivo PDF: 75.30 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007 Feb;6(2):182–7.

  2. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 populationbased studies: a systematic review. Lancet Neurol. 2009 Apr;8(4):355–69.

  3. Bonita R, Beaglehole R. Stroke prevention in poor countries. Time for action. Stroke. 2007 Nov;38(11):2871–2.

  4. Mackay J, Mensah G. The Atlas of Heart Disease and Stroke. Geneva: World Health Organization; 2004.

  5. Mathers CD, Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med [Internet]. 2006 Nov 28 [cited 2010 Jan 22];3(11):e442. Available from: http:// www.pubmedcentral.nih.gov/articlerender.fcgi?to ol=pubmed&pubmedid=17132052

  6. Ministry of Public Health (CU). Situación de Salud en Cuba. Indicadores Básicos 2009 [Internet]. Havana: Ministry of Public Health; 2009 [cited 2010 May 30]. 9 p. Available from: http:// fi les.sld.cu/dne/fi les/2010/04/cuba20092.pdf

  7. Lavados PM, Hennis AJM, Fernandes JG, Medina MT, Legetic B, Hoppe A, et al. Stroke epidemiology, prevention, and management strategies at a regional level: Latin America and the Caribbean. Lancet Neurol. 2007 Apr;6(4):362–72.

  8. Del Brutto OH, Idrovo L, Mosquera A, Navas C, Santibáñez R, Cuesta F, et al. Stroke in rural Ecuador: A three-phase, door-to-door survey. Neurology. 2004 Nov 23;63(10):1974–5.

  9. Fuster V, Voûte J. MDGs: chronic diseases are not on the agenda. Lancet. 2005 Oct 29–Nov 4;366(9496):1512–4.

  10. Buergo MA, Fernández O, Coutín G, Torres RM. Epidemiology of Cerebrovascular Diseases in Cuba, 1970 to 2006. MEDICC Review. 2008 Spring;10(2):33–8.

  11. Prince M, Ferri CP, Acosta D, Albanese E, Arizaga R, Dewey M, et al. The Protocols for the 10/66 Dementia Research Group Population-Based Research Programme. BMC Public Health. 2007 Jul 20;7:165.

  12. Prince M, Acosta D, Chiu H, Scazufca M, Varghese M; 10/66 Dementia Research Group. Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet. 2003 Mar 15;361(9):909–17.

  13. Prince MJ, Llibre JJ, Noriega L, López A, Acosta D, Albanese E, et al; 10/66 Dementia Research Group. The 10/66 Dementia Research Group’s fully operationalised DSM IV dementia computerized diagnostic algorithm, compared with the 10/66 dementia algorithm and a clinician diagnosis: a population validation study. BMC Public Health. 2008 Jun 24;8:219.

  14. Llibre JJ, Ferri CP, Acosta D, Guerra M, Huang Y, Jacob KS, et al.; 10/66 Dementia Research Group. Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey. Lancet. 2008 August 9;372(9637):464–74.

  15. O’Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al.; European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice Guidelines of the European Society of Hypertension for Clinic, Ambulatory and Self Blood Pressure Measurement. J Hypertens. 2005 Apr;23(4):697–701.

  16. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54(5):541–53.

  17. Broe GA, Akhtar AJJ, Andrews GR, Caird FI, Gilmore AJ, McLennan WJ. Neurological disorders in the elderly at home. J Neurol Neurosurg Psychiatry. 1976 Apr;39(4):362–6.

  18. National Institute of Neurological Disorders and Stroke. Classifi cation of cerebrovascular disease III. Stroke. 1990 Apr;21(4):637–76.

  19. Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003 Oct 20;3:21.

  20. Informe de la Segunda Encuesta Nacional de Factores de Riesgo y Enfermedades Crónicas. Havana: National Institute of Hygiene and Epidemiology; 2002.

  21. Berger K, Hense HW, Rothdach A, Weltermann B, Keil U. A single question about prior stroke versus a stroke questionnaire to assess stroke prevalence in populations. Neuroepidemiology. 2000 Sep–Oct;19(5):245–57.

  22. Jungehülsing GJ, Müller-Nordhorn J, Nolte CH, Roll S, Rossnagel K, Reich A, et al. Prevalence of stroke and stroke symptoms: a population-based survey of 28,090 participants. Neuroepidemiology. 2008;30(1):51–7.

  23. Howard VJ, McClure LA, Meschia JF, Pulley L, Orr SC, Friday GH. High prevalence of stroke symptoms among persons without a diagnosis of stroke or TIA in a general population: the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Arch Intern Med. 2006 Oct 9;166(18):1952–8.

  24. Pérez-Sempere A. Morbilidad por enfermedad cerebrovascular en España: incidencia y prevalencia. Rev Neurol. 1999;29(9):879–81.

  25. Boix R, del Barrio JL, Saz P, Reñé R, Manubens JM, Lobo A, et al.; Spanish Epidemiological Study Group on Ageing. Stroke prevalence among the Spanish elderly: an analysis based on screening surveys. BMC Neurol. 2006 Oct 16;6:36.

  26. Del Barrio JL, de Pedro-Cuesta J, Boix R, Acosta J, Bergareche A, Bermejo-Pareja F, et al. Dementia, Stroke and Parkinson’s D isease in Spanish Populations: a review of door-todoor prevalence surveys. Neuroepidemiology. 2005;24(4):179–88.

  27. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of populationbased studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003 Jan;2(1):43–53.

  28. Pereira A, Alvarenga H, Silva-Pereira R, Serrano- Barbosa MT. Prevalência de acidente vascular cerebral em idosos no Município de Vassouras, Rio de Janeiro, Brasil, através do rastreamento de dados do Programa Saúde da Família. Cad Saúde Pública, Rio de Janeiro. 2009;25(9):1929–36.

  29. Carod-Artal FJ, Vargas AP, Horan TA, Nunes LG. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke. 2005 May;36(5):965–70.

  30. Fernández O. Redefi nición del ataque isquémico transitorio. Rev Neurol. 2005;40(1):64.

  31. Appelros P, Stegmayr B, Terént A. Sex Differences in Stroke Epidemiology. A Systematic Review. Stroke. 2009 Apr;40(4):1082–90.

  32. Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and Ischemic Strokes Compared. Stroke Severity, Mortality, and Risk Factors. Stroke. 2009 Jun;40(6):2068–72.

  33. Lovelock CE, Redgrave JN, Briley D, Rothwell PM. Reliable estimation of the proportion of minor stroke due to intracerebral haemorrhage. Int J Stroke. 2009 Feb;4(1):6–10.

  34. Castillo V, Bogousslavsky J. Today classifi cation of stroke. Cerebrovasc Dis. 1997;7 (Suppl 3):S5–11.

  35. Béjot Y, Ben Salem D, Osseby GV, Couvreur G, Durier J, Marie C, et al. Epidemiology of ischemic stroke from atrial fi brillation in Dijon, France, from 1985 to 2006. Neurology. 2009 Jan 27;72(4):346–53.

  36. Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med. 2004 Jul 20;141(2):137–47.

  37. Sudlow C, Martínez González NA, Kim J, Clark C. Does apolipoprotein E genotype infl uence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. Stroke. 2006 Feb;37(2):364–70.

  38. Paternoster L, Martínez-González NA, Lewis S, Sudlow C. Association Between Apolipoprotein E Genotype and Carotid Intima-Media Thickness May Suggest a Specifi c Effect on Large Artery Atherothrombotic Stroke. Stroke. 2008 Jan;39(1):48–54.

  39. Leys D, Hénon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol. 2005 Nov;4(11):752–9.

  40. Jin YP, Østbye T, Feightner J, Di Legge S, Hachinski V. Joint effect of stroke and APOE 4 on dementia risk. The Canadian Study of Health and Aging. Neurology. 2008 Jan 1;70(1):9–16.

  41. Gebreyohanns M, Adams RJ. Sickle cell disease: primary stroke prevention. CNS Spectr. 2004;9:445–9.

  42. Maguire JL, deVeber G, Parkin PC. Association between iron-defi ciency anemia and stroke in young children. Pediatrics. 2007 Nov;120(5):1053–7.

  43. Kannel WB, Gordon T, Wolf PA, McNamara P. Hemoglobin and the risk of cerebral infarction: the Framingham Study. Stroke. 1972 Jul– Aug;3(4):409–20.

  44. Akins PT, Glenn S, Nemeth PM, Derdeyn CP. Carotid artery thrombus associated with severe iron-defi ciency anemia and thrombocytosis. Stroke. 1996 May;27(5):1002–5.

  45. Shahar A, Sadeh M. Severe anemia associated with transient neurological defi cits. Stroke. 1991 Sep;22(9):1201–2.

  46. Huang WY, Weng WC, Chien YY, Wu CL, Peng TI, Chen KH. Predictive factors of outcome and stroke recurrence in patients with unilateral atherosclerosis- related internal carotid artery occlusion. Neurol India. 2008 Apr–Jun;56(2):173–8.

  47. Inzitari M, Studenski S, Rosano C, Zakai NA, Longstreth WT Jr, Cushman M, et al. Anemia is associated with the progression of white matter disease in older adults with high blood pressure: the cardiovascular health study. J Am Geriatr Soc. 2008;56(10):1867–72.

  48. Peters R, Burch L, Warner J, Beckett N, Poulter R, Bulpitt C. Haemoglobin, anaemia, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr. 2008 Aug 8;8:18.




2020     |     www.medigraphic.com